These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 37076898)

  • 1. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community.
    Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid-cycle assessment strategy for understanding the opioid overdose epidemic in local communities.
    Taubenberger S; Spencer N; Chang JC; Paul N; Fabre S; Jagessar B; Trimble D; Roberto R; Gill P; Hulsey E; Arnold A; Hacker K
    Subst Abus; 2021; 42(4):888-895. PubMed ID: 33689674
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid Use Disorder Stigma and Support for Harm Reduction in Rural Counties.
    Whipple CR; Kaynak Ö; Kruis NE; Saylor E; Bonnevie E; Kensinger WS
    Subst Use Misuse; 2023; 58(14):1818-1828. PubMed ID: 37622487
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
    Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
    JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.
    Adams JW; Duprey M; Khan S; Cance J; Rice DP; Bobashev G
    Harm Reduct J; 2023 Oct; 20(1):150. PubMed ID: 37848945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploratory study of a hands-on naloxone training for rural clinicians and staff.
    Cody SL; Hines CB; Glenn CJ; Sharp-Marbury R; Newman S
    J Nurs Scholarsh; 2023 May; 55(3):599-604. PubMed ID: 36411494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study.
    Davis A; Stringer KL; Drainoni ML; Oser CB; Knudsen HK; Aldrich A; Surratt HL; Walker DM; Gilbert L; Downey DL; Gardner SD; Tan S; Lines LM; Vandergrift N; Mack N; Holloway J; Lunze K; McAlearney AS; Huerta TR; Goddard-Eckrich DA; El-Bassel N
    Int J Drug Policy; 2023 Dec; 122():104241. PubMed ID: 37890391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.
    Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ
    JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes toward syringe exchange programs in a rural Appalachian community.
    Zeller TA; Beachler T; Diaz L; Thomas RP; Heo M; Lanzillotta-Rangeley J; Litwin AH
    J Addict Dis; 2022; 40(2):227-234. PubMed ID: 34550054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.
    Walters SM; Baker R; Frank D; Fadanelli M; Rudolph AE; Zule W; Fredericksen RJ; Bolinski R; Sibley AL; Go VF; Ouellet LJ; Pho MT; Seal DW; Feinberg J; Smith G; Young AM; Stopka TJ
    Harm Reduct J; 2024 Aug; 21(1):154. PubMed ID: 39182116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations.
    Ellis MS; Kasper ZA; Gold M; Cicero TJ
    J Addict Med; 2023 Mar-Apr 01; 17(2):197-205. PubMed ID: 36148998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Use Disorder Community Education Events: Rural Public Health Implications.
    Condie AW; Judd H; Yaugher AC
    Health Educ Behav; 2023 Dec; 50(6):728-737. PubMed ID: 36382806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder.
    Nataraj N; Rikard SM; Zhang K; Jiang X; Guy GP; Rice K; Mattson CL; Gladden RM; Mustaquim DM; Illg ZN; Seth P; Noonan RK; Losby JL
    JAMA Netw Open; 2024 Apr; 7(4):e244617. PubMed ID: 38568691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care and harm reduction provider perspectives on treating older adults who use non-medical opioids: a qualitative study set in Chicago.
    Mason M; Post LA; Aggarwal R
    BMC Health Serv Res; 2023 Aug; 23(1):876. PubMed ID: 37598163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results From the POINT Pragmatic Randomized Trial: An Emergency Department-Based Peer Support Specialist Intervention to Increase Opioid Use Disorder Treatment Linkage and Reduce Recurrent Overdose.
    Watson DP; Tillson M; Taylor L; Xu H; Ouyang F; Beaudoin FL; O'Donnell D; McGuire AB
    Subst Use Addctn J; 2024 Jul; 45(3):378-389. PubMed ID: 38258819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'It's the same thing as giving them CPR training': rural first responders' perspectives on naloxone.
    Filteau MR; Green B; Kim F; McBride KA
    Harm Reduct J; 2022 Oct; 19(1):111. PubMed ID: 36192736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population.
    Bascou NA; Haslund-Gourley B; Amber-Monta K; Samson K; Goss N; Meredith D; Friedman A; Needleman A; Kumar VK; Fischer BD
    Harm Reduct J; 2022 Jan; 19(1):5. PubMed ID: 35034649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.
    Chhatwal J; Mueller PP; Chen Q; Kulkarni N; Adee M; Zarkin G; LaRochelle MR; Knudsen AB; Barbosa C
    JAMA Netw Open; 2023 Jun; 6(6):e2314925. PubMed ID: 37294571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.